Sign in
4

Changes in Ownership

Aptevo Therapeutics Inc. Filed Acc 0001019056-21-000142

Options or other derivatives

  • SVP & Chief Scientific Officer acquired 22,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Gross Jane A SVP & Chief Scientific Officer 2021-01-29 Grant or award · Stock Option (right to buy) +16,500 16,500 D: show line 1 in the form
Gross Jane A SVP & Chief Scientific Officer 2021-01-29 Grant or award · Restricted Stock Unit +5,500 5,500 D: show line 2 in the form
Loading xslF345X03/gross.xml…